Skip to content
Skip to navigation menu

 

Prof Roger Walker  -  BPharm PhD FRPharmS FFPH


If you get this message then javascript is not enabled within your browser.

Selected Publications

 

Walker R. Pharmacy research and a fair society. 2010  Int J Pharm Practice 18: 1-2.

 

Walker R, Hinchliffe A. 2010. Prescribing and sale of ophthalmic chloramphenicol following reclassification to over-the-counter availability. Int J Pharm Practice 18: 269-274. 

 

Walker R.  2010.  Determinants of health. In: Krska J (ed) Pharmacy in public health. London, Pharmaceutical Press, p17-30.

 

Waheedi S, John D, Donovan M, Walker R. 2010  Deprivation status and utilization of a non-NHS community pharmacy based cardiovascular risk assessment service.  Int J Pharm Practice 18(S2): 61-62.

 

Thomas S, Walker R. 2010. Emergency hormonal contraception provision in Bridgend 2001 – 2009. Int J Pharm Practice 18 (S2):38-39.

 

Du H, John D, Walker R. 2010. Impact of pandemic influenza A/H1N1 on the sale of over-the-counter cough, cold and flu remedies from community pharmacy. Int J Pharm Practice 18 (S2): 73.

 

Brooks CJ, Lyons RA, Jones KH, Hutton AJ, Walker R, Evans KA, Lloyd K, Ford DV. 2010. The prescribed duration algorithm: utilising “free text” from multiple primary care electronic systems.  Pharmacoepidemiol Drug Saf. 19: 983-989. 

Hinchliffe AL, Walker R. 2009 The impact of community pharmacy advice on safe storage and administration of medicines in adult care homes. Int J Pharm Practice 17: B66-B67

Walker R, Hinchliffe AL.  2009 Impact  of the reclassification of chloramphenicol eye drops and ointment on prescriptions for chloramphenicol Int J Pharm Practice  17: B67-B68.  

Walker R. Pharmacy and public health. 2009 In: Winfield AJ, Rees JA, Smith I. eds. Pharmaceutical Practice. Fourth edition. Edinburgh: Elsevier, pp 53-62.


Hinchliffe AL, Walker R. 2008 Has over-the-counter availability of chloramphenicol eye drops increased use and bacterial resistance? Int J Pharm Practice (16) C38 –C39.

Dhippayom T, Walker R.  2008 Impact of the reduction of the prescription charge in Wales on the prescribing of non-sedating antihistamines in primary care. Health Policy  87; 309-315.

Dhippayom, T.  Walker, R  2007. Impact of availability of over the counter chloramphenicol eye drops on the prescribing of chloramphenicol eye preparations.  Pharmacoepidemiol Drug Saf  (16) 589-590

Fitzgerald, K. Meecham, M. Walker, R.  2007. The impact of over the counter availability of emergency hormonal contraception on NHS supply in Wales.  Int J Pharm Practice (15), pp B48.

Walker, R.  2007. Pharmacoepidemiology, public health and pharmacy.  In: Bond, C. ed Using medicines information.  Oxford: Radcliffe Publishing, pp. 83-99.

Walker, R. 2007. Dyslipidaemia. In: Walker, R. and Whittlesea, C. eds. Textbook of clinical pharmacy and therapeutics.  Edinburgh: Elsevier, pp. 346-366.

Dhippayom T, Walker R (2006). Impact of the reduction of the prescription charge in Wales on the prescribing and sales of paracetamol. Int J Pharm Pract, 14, B39.

Dhippayom T, Walker R (2006). Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs. Pharmacy World Science 28: 194-198

Walker R, Janknegt R, Scott M (2006). Evidence based drug formularies. European Journal Healthcare Pharmacists 12: 21-22.

Walker R, Fitzgerald K, Meecham M (2006). Pharmacy sale and NHS supply of emergency hormonal contraception in primary care across Wales. Int J Pharm Pract, 14 B84-B85.

Walker R (2006). Pharmacy and public health. Hospital Pharmacy Europe. March/April, 1-2.

 

Books

Walker R & Edwards C. eds (2004).    (Croatian edition)

Klinicka farmacija i terapija. Skolska knjiga, Zagreb pp 908

Walker R & Whittlesea C eds (2007). Fourth edition.

Clinical Pharmacy and Therapeutics.  Churchill Livingstone, Edinburgh pp900

 

Other public output 


Hinchliffe, AL, Walker, R. 2008. Impact of advice on prescribing and over the counter sale of chloramphenicol during an outbreak of keratoconjunctivitis. Proceedings Faculty of Public Health annual conference Challenging Problems, Sharing Solutions. C13.

Walker, R. 2008. Manufacture of crystal meth from pseudoephedrine: a public health issue? .Proceedings Faculty of Public Health annual conference Challenging Problems, Sharing Solutions. C23.

Walker, R. 2008. Impact of the reduction of the prescription charge in Wales. Proceedings Faculty of Public Health annual conference Challenging Problems, Sharing Solutions. D24.

Hinchliffe, AL, Walker, R. 2008. Does increasing the number of medicines for sale widen inequalities Proceedings 16th UKPHA annual public health forum Community Cohesion and Empowerment.

Fitzgerald K, Walker R (2007).  Has over the counter availability of emergency hormonal contraception had any impact on NHS supply in Wales? Proceedings  15th UKPHA Annual Public Health Forum.  Generation to generation: sustainable directions for public health,  P42.1a.

Walker, R. 2007. Is the reclassification of pseudoephedrine containing medicines a public health issue?  Chemist and Druggist 7 April

Walker, R. 2007  Pseudoephedrine: serious issues to consider (letter).  Pharm J 278 pp.456.

Walker, R. Craig G 2007  Robust pharmacy response is crucial. Chemist & Druggist 6 October

Walker R, Dhippayom T (2007).  Does the reclassification of medicines create an inequality?  Proceedings 15th UKPHA Annual Public Health Forum.  Generation to generation: sustainable directions for public health,  P34.1.